Inflammation: Another Potential Mechanism Between Diabetes Mellitus and Atrial Fibrillation

American Journal of Cardiology

Volumn 101, Issue 11, 2008, Pages 1681-1682

  Liu, Tong ^a   Li, Guangping ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ASCORBIC ACID; C REACTIVE PROTEIN; CORTICOSTEROID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; INTERLEUKIN 8; OMEGA 3 FATTY ACID; TUMOR NECROSIS FACTOR ALPHA;

CARDIOMYOPATHY; CARDIOVASCULAR RISK; CARDIOVERSION; CAUSAL ATTRIBUTION; COMORBIDITY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; EXERCISE; HEART ATRIUM FIBRILLATION; HYPERTENSION; INFLAMMATION; LETTER; LIFESTYLE; OXIDATIVE STRESS; PANCREAS ISLET CELL; PATHOGENESIS; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; UPREGULATION;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES MELLITUS; DISEASE PROGRESSION; FOLLOW-UP STUDIES; HUMANS; INFLAMMATION; PROGNOSIS; RISK FACTORS; TIME FACTORS;

EID: 50949121247     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2008.04.006     Document Type: Letter

References (10)

1. Aksnes T.A., Schmieder R.E., Kjeldsen S.E., Ghani S., Hua T.A., and Julius S. Impact of new-onset diabetes mellitus on development of atrial fibrillation and heart failure in high-risk hypertension (from the VALUE trial). Am J Cardiol 101 (2008) 634-638
2. Kempf K., Rose B., Herder C., Kleophas U., Martin S., and Kolb H. Inflammation in metabolic syndrome and type 2 diabetes: impact of dietary glucose. Ann N Y Acad Sci 1084 (2006) 30-48
3. Donath M.Y., Schumann D.M., Faulenbach M., Ellingsgaard H., Perren A., and Ehses J.A. Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31 suppl (2008) S161-S164
4. Liu T, Li L, Korantzopoulos P, Goudevenos JA, Li G. Meta-analysis of association between C-reactive protein and immediate success of electrical cardioversion in persistent atrial fibrillation. Am J Cardiol In press.
5. Korantzopoulos P., Kolettis T.M., Galaris D., and Goudevenos J.A. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation. Int J Cardiol 115 (2007) 135-143
6. Liu T., Li G., Li L., and Korantzopoulos P. Association between C-reactive protein and recurrence of atrial fibrillation after successful electrical cardioversion: a meta-analysis. J Am Coll Cardiol 49 (2007) 1642-1648
7. Murray K.T., Mace L.C., and Yang Z. Nonantiarrhythmic drug therapy for atrial fibrillation. Heart Rhythm 4 (2007) S88-S90
8. Liu T., Li G.P., and Huang T.G. Anti-inflammatory therapies in atrial fibrillation. Int J Cardiol 104 (2005) 359-360
9. Liu T., Li L., Korantzopoulos P., Liu E., and Li G. Statin use and development of atrial fibrillation: a systematic review and meta-analysis of randomized clinical trials and observational studies. Int J Cardiol 126 (2008) 160-170
10. Liu T, Korantzopoulos P, Li G, Li J. The potential role of thiazolidinediones in atrial fibrillation. Int J Cardiol In press.